May 13 |
Zai Lab Announces Approval of AUGTYRO™ (repotrectinib) for Patients with ROS1-positive NSCLC by China’s NMPA
|
May 11 |
Zai Lab Limited (NASDAQ:ZLAB) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
|
May 10 |
Zai Lab Limited (NASDAQ:ZLAB) Q1 2024 Earnings Call Transcript
|
May 9 |
Zai Lab Limited (ZLAB) Q1 2024 Earnings Call Transcript
|
May 9 |
Spectrum Brands Posts Upbeat Results, Joins AerSale, Sinclair, ICU Medical And Other Big Stocks Moving Higher On Thursday
|
May 9 |
Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2
|
May 8 |
Zai Lab GAAP EPADS of -$0.55 beats by $0.39, revenue of $87.15M beats by $11.91M
|
May 8 |
Zai Lab Announces First Quarter 2024 Financial Results and Recent Corporate Updates
|
May 7 |
Zai Lab Q1 2024 Earnings Preview
|
Apr 30 |
Zai Lab Limited's (NASDAQ:ZLAB) Profit Outlook
|